Worldwide Vice President, Business Development
Johnson & Johnson
Aileen Stockburger is currently the Worldwide Vice President of Business Development for the DePuy Synthes Group of Johnson & Johnson. In this position, she oversees the group’s merger and acquisition activities, including deal structuring, negotiations, contract design and review, and deal terms. Most recently she led Johnson & Johnson’s efforts to acquire Synthes for approximately $21BN, Johnson & Johnson’s largest acquisition. She also leads the Group’s strategic planning efforts. Additionally, she led the efforts to divest the DePuy Trauma business and acquire Micrus Endovascular.
Aileen has been with Johnson & Johnson for over 25 years with roles in Consumer, Medical Devices and Corporate. She has completed numerous M&A transactions across the corporation, including BD leadership roles in Synthes ($21BN), Pfizer Consumer HealthCare ($16.5BN), Aveeno, BabyCenter, OraPharma, DePuy, DePuy Mitek, Kodak Clinical Diagnostics and Neutrogena.
Before joining Johnson & Johnson, Aileen spent three years at Coopers and Lybrand, where she earned her CPA certification. She received her BS and MBA from the Wharton School.